Internationally recognized services available through BC Cancer to internal and external researchers and collaborators include the following.
Genome Sciences Centre
The GSC's technology platform is a high-throughput, large-scale DNA and RNA sequencing and analysis facility that has been designed to maximize analytical capacity, diversity, efficiency, scalability and flexibility. The platform is one of the largest of its type in Canada and is well recognized internationally.
Terry Fox Laboratory
BC Cancer Investigational Drug Program (IDP) provides fee-for-service preclinical research services and contract manufacturing for academic and private sector researchers. IDP’s mandate is to help its research partners develop promising therapeutic compounds to the point where they can be tested in early phase human clinical trials.
Deeley Research Centre
The Molecular and Cellular Immunology Core (MCIC) is a full service facility specializing in advanced molecular, genomic and histological methods including multicolour immunohistochemistry (mcIHC) and immunofluorescence (mcIF), automated image analysis, laser capture microdissection, multispectral flow cytometry, and single-cell sequencing.
MCIC supports academic and industry projects both nationally and internationally, ranging from investigator-driven basic research, to correlative studies for clinical trials, to fee-for-service projects with industrial clients.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.